May 14 (Reuters) - BG Medicine Inc BGMD.O :
* Reports first quarter 2015 financial results
* Q1 loss per share $0.04
* We expect to reverse the sequential decline in revenues that we have
experienced over the last three quarters (in 2015)"
* Says "we are experiencing modest revenue growth from our sales to the
majority of our clinical laboratory customers"
* Anticipate recognizing incremental revenues from u.s. market introduction of
automated galectin-3 testing in latter half of 2015
* Says for the full year 2015, we continue to expect to decrease our operating
cash burn as compared to 2014
* Source text for Eikon ID:nGNXVDOROa
* Further company coverage BGMD.O
((Bengaluru Newsroom; +1 646 223 8780))